CNS Pharmaceuticals Inc (CNSP) — Strategic Asset Allocation Index
CNS Pharmaceuticals Inc (CNSP) has a Strategic Asset Allocation Index of 0.1% as of June 2023. Strategic assets (PP&E of $3.38K plus long-term investments of $-) total $3.38K, measured against net assets of $2.45 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See CNSP equity financing ratio to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
CNS Pharmaceuticals Inc Strategic Asset Allocation Index (2019–2021)
This chart shows how CNS Pharmaceuticals Inc's Strategic Asset Allocation Index has evolved across 3 annual periods from 2019 to 2021. As of June 2023, the index stands at 0.1%, representing strategic assets of $3.38K against net assets of $2.45 Million USD. For live market cap and overall valuation, see market value of CNS Pharmaceuticals Inc.
Annual Strategic Asset Allocation Index for CNS Pharmaceuticals Inc (2019–2021)
The table below presents the year-by-year Strategic Asset Allocation Index for CNS Pharmaceuticals Inc from 2019 to 2021, covering 3 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See CNS Pharmaceuticals Inc (CNSP) shareholders funds for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 0.2% | $16.11K | $16.11K | $- | $6.62 Million | ▲ +0.1 pp |
| 2020 | 0.2% | $23.43K | $23.43K | $- | $13.95 Million | ▼ -0.1 pp |
| 2019 | 0.2% | $18.16K | $18.16K | $- | $7.60 Million | — |